Raymond James & Associates increased its stake in Abrdn Healthcare Investors (NYSE:HQH - Free Report) by 79.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 355,205 shares of the financial services provider's stock after buying an additional 157,618 shares during the period. Raymond James & Associates owned 0.70% of Abrdn Healthcare Investors worth $6,614,000 at the end of the most recent reporting period.
A number of other institutional investors also recently bought and sold shares of HQH. Cetera Investment Advisers grew its holdings in Abrdn Healthcare Investors by 46.8% in the first quarter. Cetera Investment Advisers now owns 177,208 shares of the financial services provider's stock worth $2,988,000 after purchasing an additional 56,521 shares during the period. City of London Investment Management Co. Ltd. grew its holdings in Abrdn Healthcare Investors by 155.4% in the second quarter. City of London Investment Management Co. Ltd. now owns 68,971 shares of the financial services provider's stock worth $1,204,000 after purchasing an additional 41,971 shares during the period. NINE MASTS CAPITAL Ltd purchased a new stake in Abrdn Healthcare Investors in the second quarter worth about $1,350,000. Sanctuary Advisors LLC purchased a new stake in shares of Abrdn Healthcare Investors during the second quarter valued at approximately $939,000. Finally, Commonwealth Equity Services LLC grew its holdings in shares of Abrdn Healthcare Investors by 3.8% during the first quarter. Commonwealth Equity Services LLC now owns 82,674 shares of the financial services provider's stock valued at $1,394,000 after buying an additional 3,015 shares during the last quarter. 32.60% of the stock is owned by institutional investors.
Abrdn Healthcare Investors Trading Up 0.7 %
Shares of NYSE:HQH traded up $0.13 during trading on Friday, reaching $18.16. 228,211 shares of the stock traded hands, compared to its average volume of 156,674. The stock has a 50-day moving average of $18.62 and a two-hundred day moving average of $17.88. Abrdn Healthcare Investors has a 52-week low of $14.58 and a 52-week high of $19.79.
Abrdn Healthcare Investors Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Monday, September 30th. Investors of record on Friday, August 23rd were issued a $0.59 dividend. This represents a $2.36 annualized dividend and a yield of 13.00%. The ex-dividend date was Friday, August 23rd.
Abrdn Healthcare Investors Profile
(
Free Report)
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.
Read More
Before you consider Abrdn Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Abrdn Healthcare Investors wasn't on the list.
While Abrdn Healthcare Investors currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
